ATE295882T1 - Eine methode zur in vitro molekularen evolution der proteinfunktion - Google Patents

Eine methode zur in vitro molekularen evolution der proteinfunktion

Info

Publication number
ATE295882T1
ATE295882T1 AT01985402T AT01985402T ATE295882T1 AT E295882 T1 ATE295882 T1 AT E295882T1 AT 01985402 T AT01985402 T AT 01985402T AT 01985402 T AT01985402 T AT 01985402T AT E295882 T1 ATE295882 T1 AT E295882T1
Authority
AT
Austria
Prior art keywords
single stranded
fragments
sequences
protein motifs
polynucleotide sequences
Prior art date
Application number
AT01985402T
Other languages
English (en)
Inventor
Roland Carlsson
Christina Furebring
Hager Ann-Christin Malmborg
Carl Borrebaeck
Original Assignee
Alligator Bioscience Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26245418&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE295882(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0030252A external-priority patent/GB2370038B/en
Priority claimed from US09/734,801 external-priority patent/US6958213B2/en
Application filed by Alligator Bioscience Ab filed Critical Alligator Bioscience Ab
Application granted granted Critical
Publication of ATE295882T1 publication Critical patent/ATE295882T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1031—Mutagenizing nucleic acids mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01985402T 2000-12-12 2001-12-12 Eine methode zur in vitro molekularen evolution der proteinfunktion ATE295882T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0030252A GB2370038B (en) 2000-12-12 2000-12-12 A method for in vitro molecular evolution of protein function
US09/734,801 US6958213B2 (en) 2000-12-12 2000-12-12 Method for in vitro molecular evolution of protein function
PCT/EP2001/014744 WO2002048351A2 (en) 2000-12-12 2001-12-12 A method for in vitro molecular evolution of protein function

Publications (1)

Publication Number Publication Date
ATE295882T1 true ATE295882T1 (de) 2005-06-15

Family

ID=26245418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01985402T ATE295882T1 (de) 2000-12-12 2001-12-12 Eine methode zur in vitro molekularen evolution der proteinfunktion

Country Status (10)

Country Link
EP (1) EP1341909B2 (de)
JP (1) JP4430303B2 (de)
AT (1) ATE295882T1 (de)
AU (2) AU3457202A (de)
CA (1) CA2430582C (de)
DE (1) DE60110926T3 (de)
DK (1) DK200300821A (de)
ES (1) ES2244670T5 (de)
PT (1) PT1341909E (de)
WO (1) WO2002048351A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153655B2 (en) 1998-06-16 2006-12-26 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
US6958213B2 (en) 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
US20030036641A1 (en) * 2001-01-31 2003-02-20 Padgett Hal S. Methods for homology-driven reassembly of nucleic acid sequences
CA2485506C (en) 2002-05-17 2012-02-28 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
WO2004016811A2 (en) * 2002-08-19 2004-02-26 Danmarks Tekniske Universitet (Dtu) Methods and kit for genes shuffling using tagged primers
GB2432366B (en) * 2005-11-19 2007-11-21 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
GB0607798D0 (en) 2006-04-20 2006-05-31 Alligator Bioscience Ab Novel polypeptides and use thereof
GB0708376D0 (en) 2007-05-01 2007-06-06 Alligator Bioscience Ab Novel polypeptides and uses thereof
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
GB0905790D0 (en) 2009-04-03 2009-05-20 Alligator Bioscience Ab Novel polypeptides and use thereof
GB0920258D0 (en) 2009-11-19 2010-01-06 Alligator Bioscience Ab New medical agents and use thereof
GB201115280D0 (en) 2011-09-05 2011-10-19 Alligator Bioscience Ab Antibodies, uses and methods
GB201311487D0 (en) 2013-06-27 2013-08-14 Alligator Bioscience Ab Bispecific molecules
GB201311475D0 (en) 2013-06-27 2013-08-14 Alligator Bioscience Ab Polypeptides
KR102443258B1 (ko) 2014-08-12 2022-09-14 엘리게이터 바이오사이언스 에이비 항 cd40 항체에 의한 병용 치료제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117679A (en) * 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5851804A (en) * 1996-05-06 1998-12-22 Apollon, Inc. Chimeric kanamycin resistance gene
GB9712512D0 (en) * 1997-06-16 1997-08-20 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
AU5030900A (en) * 1999-05-21 2000-12-12 Penn State Research Foundation, The Construction of incremental truncation libraries

Also Published As

Publication number Publication date
ES2244670T5 (es) 2012-08-02
DE60110926T2 (de) 2006-03-23
EP1341909B2 (de) 2012-04-11
DK200300821A (da) 2003-08-12
JP4430303B2 (ja) 2010-03-10
WO2002048351A2 (en) 2002-06-20
CA2430582A1 (en) 2002-06-20
DE60110926D1 (de) 2005-06-23
WO2002048351A3 (en) 2003-06-05
CA2430582C (en) 2012-12-04
PT1341909E (pt) 2005-10-31
EP1341909A2 (de) 2003-09-10
EP1341909B8 (de) 2006-05-03
JP2004515248A (ja) 2004-05-27
DE60110926T3 (de) 2012-06-14
AU3457202A (en) 2002-06-24
AU2002234572B2 (en) 2006-07-06
ES2244670T3 (es) 2005-12-16
EP1341909B1 (de) 2005-05-18

Similar Documents

Publication Publication Date Title
DE60110926D1 (de) Eine methode zur in vitro molekularen evolution der proteinfunktion
DE60312507D1 (de) Eine methode zur in vitro molekularen evolution der proteinfunktion
ATE448301T1 (de) Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten
ATE409235T1 (de) Verfahren zur herstellung von ascorbinsäurezwischenprodukten in wirtszellen
DE60009323D1 (de) Methoden und zusammensetzungen zur linearen isothermalen amplifikation von polynukleotidsequenzen
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
DE69433487D1 (de) Methoden und zusammensetzungen zur effizienten nukleinsaeuresequenzierung
DE59908447D1 (de) Verfahren zur Herstellung von hantelförmigen DNA-Molekülen als Expressionskonstrukte
NZ333128A (en) Engineered human DNase I with DNA hydrolytic activity at least 50 percent greater than native human DNase I
ATE405676T1 (de) Verfahren zur erzeugung doppelsträngiger dna mit einem 3'-einzelstranganteil und verwendungen dieser komplexe zur rekombination
DE69943286D1 (de) Fluoreszierende proteine aus nicht-biolumineszenten arten der klasse anthozoa, gene die diese proteine kodieren und deren verwendungen
ATE243753T1 (de) Mch4 und mch5, apoptotische proteasen, dafür kodierende nukleinsäure und verfahren zur verwendung
ATE335086T1 (de) Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten
AU4744501A (en) Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
JP2004515248A5 (de)
ATE540110T1 (de) Oligonukleotid-leiterkonstruktion und system zur erzeugung von molekularer vielfalt
FR2710074B1 (fr) Gène GRB3-3, ses variants et leurs utilisations.
ATE271609T1 (de) Mch3, eine apoptosis-protease, kodierende nukleinsäuren und methoden zur verwendung
GB2432366B (en) A method for in vitro molecular evolution of protein function
WO1990009457A3 (en) Oligonucleotide primer pairs for sequence independent gene amplification and methods which employ them
PE20399A1 (es) Muteina ob
ATE303444T1 (de) Nukleinsäuren kodierend für das tmk gen
CO4440441A1 (es) Enzima dextranasa, metodo para su produccion y adn que la codifica
BR9915537A (pt) Gene prv-1 e sua utilização
ES2190866A1 (es) Metodo para la insercion eficiente en sitios especificos de cualquier adn diana de intrones del grupo ii.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1341909

Country of ref document: EP